(Q43939644)

28 November 2017

title

Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania (English)

1 reference

28 November 2017

0 references

1 reference

artemether/lumefantrine

1 reference

3

1 reference

28 November 2017

Lars L Gustafsson

7

0 references

Max Petzold

series ordinal

5

object named as

Max Petzold

1 reference

28 November 2017

4

Zul Premji

1 reference

28 November 2017

Daudi O Simba

1

1 reference

28 November 2017

Deodatus Kakoko

series ordinal

2

1 reference

28 November 2017

Margarita Mahindi

series ordinal

6

1 reference

28 November 2017

publication date

17 November 2011

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

28 November 2017

published in

1 reference

28 November 2017

volume

106

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

3-9

1 reference

Caregivers' acceptance of using artesunate suppositories for treating childhood malaria in Papua New Guinea.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Local understanding, perceptions and reported practices of mothers/guardians and health workers on childhood malaria in a Tanzanian district--implications for malaria control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Feasibility and acceptability of the use of artemether‐lumefantrine in the home management of uncomplicated malaria in children 6–59 months old in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Who Gets Prompt Access to Artemisinin-Based Combination Therapy? A Prospective Community-Based Study in Children from Rural Kilosa, Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Comprehensive community effectiveness of health care. A study of malaria treatment in children and adults in rural Burkina Faso

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Community effectiveness of malaria treatment in Uganda--a long way to Abuja targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Improving adherence to malaria treatment for children: The use of pre-packed chloroquine tablets vs. chloroquine syrup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Local fever illness classifications: implications for home management of malaria strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Understanding caretakers' dilemma in deciding whether or not to adhere with referral advice after pre-referral treatment with rectal artesunate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Care-seeking patterns for fatal malaria in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

A field-adapted sampling and HPLC quantification method for lumefantrine and its desbutyl metabolite in whole blood spotted on filter paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

How do patients use antimalarial drugs? A review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Malaria disaster in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

How much fat is necessary to optimize lumefantrine oral bioavailability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Factors influencing adherence to referral advice following pre-referral treatment with artesunate suppositories in children in rural Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Antimalarial drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

Low validity of caretakers' reports on use of selected antimalarials and antibiotics in children with severe pneumonia at an urban hospital in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.09.006

10.1016/J.TRSTMH.2011.09.006

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference